Mark W J Ferguson
Overview
Explore the profile of Mark W J Ferguson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jabeen S, Clough E, Thomlinson A, Chadwick S, Ferguson M, Shah M
Burns
. 2019 Feb;
45(3):531-542.
PMID: 30739729
Wound healing is a complex multistep process which is temporally and spatially controlled. In partial thickness wounds, regeneration is possible from the stem cells in the edges of the wound...
2.
Benedictus R, Miedema F, Ferguson M
Nature
. 2016 Oct;
538(7626):453-455.
PMID: 27786219
No abstract available.
3.
Wong J, Metcalfe A, Wong R, Bush J, Platt C, Garcon A, et al.
PLoS One
. 2014 Nov;
9(11):e112672.
PMID: 25383548
Repaired tendons may be complicated by progressive fibrosis, causing adhesion formation or tendon softening leading to tendon rupture and subsequent reduced range of motion. There are few therapies available which...
4.
Chadwick S, Yip C, Ferguson M, Shah M
J Anat
. 2013 May;
223(1):74-82.
PMID: 23668313
Cutaneous scarring is currently an inevitable outcome following skin injury. Abnormal pigmentation within scars makes them more noticeable, causing distress for patients, particularly as there is no reliable and effective...
5.
Henderson J, Ferguson M, Terenghi G
J Plast Reconstr Aesthet Surg
. 2012 Jan;
65(4):e80-6.
PMID: 22240245
Background: Wounds deprived of innervation fail to heal normally, and hypertrophic scars may be abnormally innervated. Manipulation of wounds alters the subsequent degree of scarring, and isoforms of transforming growth...
6.
Henderson J, Ferguson M, Terenghi G
Plast Reconstr Surg
. 2011 Dec;
129(1):223e-224e.
PMID: 22186580
No abstract available.
7.
Little J, Murdy R, Cossar N, Getliffe K, Hanak J, Ferguson M
J Immunoassay Immunochem
. 2011 Dec;
33(1):66-81.
PMID: 22181822
Juvista™ drug product contains human recombinant active transforming growth factor beta 3 (TGFβ3; avotermin). Juvista is being developed for the prevention and reduction of human scarring. Phase II and III...
8.
Buckley G, Wong J, Metcalfe A, Ferguson M
J Anat
. 2011 Nov;
220(1):3-12.
PMID: 22066944
The MRL/MpJ mouse displays the rare ability amongst mammals to heal injured ear tissue without scarring. Numerous studies have shown that the formation of a blastema-like structure leads to subsequent...
9.
Occleston N, OKane S, Laverty H, Cooper M, Fairlamb D, Mason T, et al.
Wound Repair Regen
. 2011 Jul;
19 Suppl 1:s38-48.
PMID: 21793965
Scarring in the skin following surgery or trauma may be associated with adverse aesthetic, functional, growth and psychological effects, such that both physicians and patients regard it as important to...
10.
Bush J, McGrouther D, Young V, Herndon D, Longaker M, Mustoe T, et al.
Wound Repair Regen
. 2011 Jul;
19 Suppl 1:s32-7.
PMID: 21793964
Cutaneous scarring is an enormous medical problem with approximately 100 million patients acquiring scars each year. Scar prevention/reduction represents a significant, and largely unmet, clinical need. Research into the prophylactic...